NCT03602482

Brief Summary

The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
139

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 23, 2018

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2019

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 14, 2021

Completed
Last Updated

April 14, 2021

Status Verified

March 1, 2021

Enrollment Period

1.5 years

First QC Date

July 9, 2018

Results QC Date

July 21, 2020

Last Update Submit

March 19, 2021

Conditions

Keywords

postural tachycardia syndromecognition

Outcome Measures

Primary Outcomes (1)

  • Executive Function (Stroop Word-color Test)

    Testing scores are normalized using T-scores for predicted values based on age and education for each participant. Scores range from 0 to 100. Higher numbers indicate better cognition. Testing will be performed while participants are supine and standing.

    1 hour

Secondary Outcomes (3)

  • Attention Score Using Cogstate Identification Task

    1 hour

  • Number of Participants With Hypermobile Ehlers-Danlos Syndrome (hEDS)

    1 hour

  • Heart Rate Standing Minus Heart Rate Supine

    1 hour

Study Arms (2)

Standing

EXPERIMENTAL

Participants will complete cognitive testing while standing.

Behavioral: Standing

Supine

ACTIVE COMPARATOR

Participants will complete cognitive testing while supine.

Behavioral: Supine

Interventions

StandingBEHAVIORAL

Participants will stand and complete cognitive tests.

Standing
SupineBEHAVIORAL

Participants will complete cognitive tests while supine.

Supine

Eligibility Criteria

Age13 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Previously diagnosed with POTS, or healthy control
  • Age between 13-60 years
  • Participants may be any race, ethnicity, sex, or gender
  • Able and willing to provide informed consent

You may not qualify if:

  • Inability to give, or withdrawal of, informed consent
  • Age ≤ 13 or ≥ 61 years
  • Prisoners
  • Unable to stand

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State College of Medicine

Hershey, Pennsylvania, 17111, United States

Location

MeSH Terms

Conditions

Postural Orthostatic Tachycardia SyndromeEhlers-Danlos Syndrome

Interventions

Standing PositionSupine Position

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesHemostatic DisordersVascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr. Amanda J. Miller
Organization
Pennsylvania State University College of Medicine

Study Officials

  • Amanda J Miller, Ph.D.

    Penn State College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Fellow

Study Record Dates

First Submitted

July 9, 2018

First Posted

July 26, 2018

Study Start

June 23, 2018

Primary Completion

December 17, 2019

Study Completion

December 17, 2019

Last Updated

April 14, 2021

Results First Posted

April 14, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations